Groundbreaking Funding for Brain Injury Solutions
Sense Neuro Diagnostics is excited to announce a significant achievement in its commitment to advancing brain injury detection technology. Recently, the company was awarded a $2 million contract through the Department of Defense's Congressionally Directed Medical Research Programs (CDMRP) related to its innovative device, NeuroHawk. This investment aims to fuel clinical trials for this cutting-edge technology, focusing on detecting brain hemorrhages and providing rapid diagnoses for Traumatic Brain Injury (TBI), especially crucial in high-stakes environments.
Understanding the NeuroHawk Device
The NeuroHawk stands out as a non-invasive device designed to efficiently diagnose brain injuries and localize hemorrhages. The clinical trial is slated to commence in the near future, marking a crucial step forward in the evaluation of this state-of-the-art technology. With the company’s commitment to innovation, this funding will enhance the NeuroHawk's capability to perform in various settings, thereby improving the timely diagnosis of TBI.
Transforming TBI Detection in High-Pressure Situations
As modern warfare evolves, so does the technology required to keep servicemen and women safe. TBI has become an alarming trend among military personnel, affecting hundreds of thousands over the last two decades. Traditional diagnostic methods are often subjective, risking delays in crucial care. With the NeuroHawk device, however, armed forces healthcare professionals will have access to objective data, enabling swift decisions in the most urgent circumstances. This device employs advanced radio frequency technology to rapidly assess brain injuries, ensuring that help reaches those in need without unnecessary delay.
Broader Applications Beyond the Battlefield
While the substantial contract from the military underscores confidence in the NeuroHawk, its potential extends far beyond combat applications. Sense Neuro Diagnostics is actively exploring its integration within hospital environments and emergency medical services (EMS). The company aims to submit its device for FDA clearance soon, heralding a new era in brain injury treatment across various sectors. This proactive approach signifies a commitment to enhancing medical capabilities in diverse health landscapes.
Commitment to Global Health Improvement
CEO Geoff Klass emphasizes the significance of this funding: "Receiving support from the military directly reflects the transformative potential of our technology. It represents a chance to redefine the protocols within brain injury care both on the battlefield and at hospitals." This venture not only promises to change current diagnostics but aims to elevate the standard of care for patients suffering from strokes and other severe brain conditions.
About Sense Neuro Diagnostics
Sense Neuro Diagnostics is dedicated to pioneering medical technology that enhances the diagnosis and monitoring of brain injuries. Their mission focuses on developing practical, non-invasive solutions, with the goal of improving outcomes for stroke and brain injury patients by providing healthcare professionals with real-time, actionable data. With the NeuroHawk, they're setting the stage for significant advancements in both military and civilian healthcare.
Media Inquiries
For further information, please contact Suzanne Murray, CEO at Marca 360. She can be reached at 513.205.7662 or via email at Suzanne@Marca-360.com.
Frequently Asked Questions
What is the NeuroHawk device?
The NeuroHawk is a non-invasive scanner designed to rapidly diagnose and monitor brain injuries, specifically for detecting hemorrhages associated with TBI.
How much funding did Sense Neuro Diagnostics receive?
The company was awarded a $2 million contract from the Department of Defense to support clinical trials of the NeuroHawk technology.
What are the potential applications of the NeuroHawk?
While initially aimed at military applications, the NeuroHawk may also be adapted for use in hospitals and emergency medical services for patients with strokes and brain injuries.
When will clinical trials for the NeuroHawk begin?
Clinical trials for the NeuroHawk device are scheduled to start in the near future, with the goal of evaluating its effectiveness in diagnosing brain injuries.
Who can I contact for more information about Sense Neuro Diagnostics?
For inquiries regarding the company and its technology, you may contact Suzanne Murray at 513.205.7662 or via email at Suzanne@Marca-360.com.
